Dashboard
Manage Tickers

RADX Radiopharm Theranostics Ltd


$ 7.11 $ 0.01 (0.14 %)    

Tuesday, 14-Oct-2025 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 606.37 $ 0.00 (0 %)
DIA $ 463.89 $ 0.00 (0 %)
SPY $ 668.28 $ 0.00 (0 %)
TLT $ 91.08 $ 0.00 (0 %)
GLD $ 389.64 $ 0.00 (0 %)
$ 7.11
$ 7.09
$ 6.70 x 10
$ 17.00 x 1,000
-- - --
$ 3.50 - $ 50.82
32,461
na
na
$ 0.68
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Trading Halt: Halted at 7:01:04 a.m. ET - ...
10/15/2025 11:01:08

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/02/2025 12:09:25

Core News & Articles
Radiopharm Theranostics Receives Recommend...
10/01/2025 12:12:33

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/01/2025 12:09:24

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
09/15/2025 21:06:07

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/20/2025 17:06:31

Core News & Articles
Radiopharm Theranostics Reported FY25 Cash...
07/29/2025 11:41:24

Financial updateThe following is a summary of the Appendix 4C Cash Flow Report:The year-end closing cash balance was $29.12 mil...

Core News & Articles
Radiopharm Theranostics Announces That The...
07/28/2025 12:10:39

- Radiopharm Theranostics (ASX: RAD, NASDAQ:RADX, "Radiopharm" or the "Company"), a clinical-stage biopharmaceu...

Core News & Articles
Radiopharm Gets Green Light to Test Tumor-...
07/28/2025 11:47:09

Radiopharm Theranostics (ASX: RAD, NASDAQ:RADX, &, ldquo, Radiopharm&, rdquo, or the &, ldquo, Company&, rdquo,...

Core News & Articles
Brookline Capital Initiates Coverage On Ra...
07/21/2025 12:33:57

Brookline Capital analyst Kemp Dolliver initiates coverage on Radiopharm Theranostics (NASDAQ:RADX) with a Buy rating and an...

Core News & Articles
Radiopharm Theranostics Signs Supply Agree...
06/24/2025 12:15:37

RAD 402 preclinical data package complete; demonstrates safety and promising biodistribution profileEthics approval and Phase 1...

Core News & Articles
Radiopharm Theranostics' RAD101 Receives F...
06/11/2025 12:10:31

Radiopharm Theranostics (ASX:RAD, "Radiopharm" or the "Company"), a clinical-stage biopharmaceutical company fo...

Core News & Articles
Radiopharm Theranostics Doses First Patien...
06/04/2025 12:07:00

Core News & Articles
UPDATE: Radiopharm Theranostics Advances T...
06/02/2025 16:05:01

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
05/23/2025 17:06:46

Core News & Articles
ITM And Radiopharm Sign Supply Agreement F...
05/19/2025 12:04:33

ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics ((ASX:RAD,...

Core News & Articles
Radiopharm Theranostics Announces Data and...
05/12/2025 12:02:07

Core News & Articles
Maxim Group Initiates Coverage On Radiopha...
05/01/2025 12:30:15

Maxim Group analyst Michael Okunewitch initiates coverage on Radiopharm Theranostics (NASDAQ:RADX) with a Buy rating and ann...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
04/29/2025 21:05:49

Core News & Articles
Radiopharm Theranostics Doses First Patien...
04/28/2025 12:02:05

Phase 2b study evaluating diagnostic performance of 18F-RAD101 for suspected recurrent brain metastases from solid tumors of di...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION